Specialty neurology pharmaceutical company advancing movement and neurodegenerative treatments
Merz Therapeutics operates a specialty pharma business focused on neurology, movement disorders, and neurodegenerative conditions across 80+ countries. The tech stack is operationally mature—Salesforce, Veeva, SAP, and SAS for core pharma workflows—but hiring is concentrated in sales (8 roles) and healthcare (6 roles), with clinical data workflow optimization and go-to-market inefficiency flagged as pain points. This suggests active scaling in field execution and commercial operations rather than product/R&D expansion.
Notable leadership hires: Regulatory Lead
Merz Therapeutics is a specialty pharmaceutical company headquartered in Frankfurt am Main, Germany, and part of the Merz Group, a privately held family business with 117 years of history. The company develops and commercializes innovative treatments in movement disorders, neurodegenerative conditions, liver disease, and related specialties, operating in over 80 countries. With 1,001–5,000 employees, Merz combines clinical science with patient-focused care delivery. Current operational priorities include preparing medical communities for upcoming product launches, optimizing clinical data workflows, entering new markets through partnerships, and improving commercial execution and sales force effectiveness.
Merz runs on Salesforce, Veeva (clinical/regulatory), SAP (enterprise), SAS (analytics), SQL, Python, Power BI, Microsoft 365, and Docebo (training). Personio handles HR operations.
Current projects include preparing medical communities for product launches, clinical data workflow optimization, developing HCP engagement plans, launch excellence planning, market entry via partnerships, and international pharmacovigilance system development.
Other companies in the same industry, closest in size